Reaffirms

The Ensign Group Reports Second Quarter 2009 Earnings of $0.39 per Share; Reaffirms 2009 EPS Guidance

MISSION VIEJO, Calif., Aug. 6 /PRNewswire-FirstCall/ -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services and assisted living companies, today reported record results for the second quarter of f...

Intelident Solutions Reaffirms Proposal to Acquire Zila

TAMPA, Fla., July 15 /PRNewswire/ -- Intelident Solutions, Inc. ("Intelident") today announced that it has reaffirmed its offer to acquire Zila, Inc. (NasdaqCM: ZILA) for $0.42 per Common share and $0.48 per Preferred share. In addition, Intelident announced that it has filed ...

The Ensign Group Reports First Quarter 2009 Earnings of $0.38 per Share; Reaffirms 2009 Guidance

Conference Call and Webcast Scheduled for May 7, 2009 at 10:30 a.m. PT MISSION VIEJO, Calif., May 6 /PRNewswire-FirstCall/ -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services and assisted living companies, ...

Smithfield Foods Reaffirms No Incidence of A(H1N1) In Any of Its Herds or Employees

Smithfield, Va., May 3 /PRNewswire-FirstCall/ -- Smithfield Foods, Inc. (NYSE: SFD ) today reaffirmed that there is no evidence of the presence of A(H1N1) influenza in any of the company's swine herds or in its employees at any of its worldwide operations, including those in the United States. ...

Amber Court Assisted Living Communities Reaffirms Its Commitment To Seniors On Medicaid

Amber Court ( http://www.AmberCourtAL.com ) reaffirms its commitment to seniors on Medicaid. New Jersey Public Advocate Ronald K. Chen's investigation of Wisconsin-based Assisted Living Concepts, revealed a history of evictions when residents depleted their personal savings. ...

Amber Court Assisted Living Communities Reaffirms its Commitment to Seniors on Medicaid

Amber Court ( http://www.AmberCourtAL.com ) reaffirms its commitment to seniors on Medicaid. New Jersey Public Advocate Ronald K. Chen's investigation of Wisconsin-based Assisted Living Concepts, revealed a history of evictions when residents depleted their personal savings. WESTBU...

ESC reaffirms advice on cardiovascular risks associated with long-haul flights

Following a review by The Lancet of the medical issues associated with commercial air travel, the European Society of Cardiology has reaffirmed its advice about the risks of venous thromboembolism (VTE), whose risk, according to The Lancet , is increased "up to four-fold" by long-haul flight. ...

China Sky One Medical, Inc. Reaffirms Guidance for 2008 Revenue and Net Income and Provides Business Update

HARBIN, China, Feb. 10 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. (''China Sky One Medical'' or ''the Company'') (Nasdaq: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China (''PRC''), today reaffirmed i...

The Ensign Group, Inc. Reports Third Quarter 2008 Earnings; Reaffirms 2008 Guidance

Conference Call and Webcast Scheduled for October 31, 2008 at 11:30 am ET MISSION VIEJO, Calif., Oct. 30 /PRNewswire-FirstCall/ -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services and assisted living companies, ...

HealthSouth Reaffirms Business Fundamentals and Full Year 2008 Guidance

BIRMINGHAM, Ala., Oct. 27 /PRNewswire-FirstCall/ -- HealthSouth Corporation (NYSE: HLS ) today, in response to recent market movement of its stock price, is reaffirming its previously announced full year 2008 guidance and the continued strength of its business fundamentals, which the Company ...

Reaffirms in Medical Technology

Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia

BRIDGEWATER, N.J., March 11 /PRNewswire/ -- The totality of scientific data submitted in recent months to the U.S. Food and Drug Administration (FDA) in preparation for the March 13th Oncologic Drugs Advisory Committee Meeting (ODAC) reaffirms that erythropoiesis-stimulating agents (ESAs) are ...

Study Confirms Effectiveness of Innovative Prism Glasses For Hemianopia Patients

...chepens Eye Research Institute and inventor of the glasses. The study, published in the May 2009 issue of Optometry and Vision Science, not only reaffirms previous clinical studies, but also adds a deeper understanding of the neurological processes at play when a patient uses prisms for this purpose, add...

Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmer's Trabecular Metal(TM) Technology

... clinical outcomes up to 10 years after total hip arthroplasty (THA) using products made with Zimmer's Trabecular Metal Technology. "This study reaffirms the positive clinical outcomes associated with using Trabecular Metal technology," commented Cheryl Blanchard, PhD, Zimmer's Senior Vice President, ...

Rendell Administration Announces Health Research Grants From Tobacco Settlement Funds

...will support research that seeks to find answers to some of Pennsylvania's most pressing health issues," said Secretary James. "This announcement also reaffirms Governor Rendell's commitment to use tobacco settlement dollars to improve public health and maintain Pennsylvania's internationally recognized leader...

Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program

...ization criteria. Omeros' schizophrenia product candidates inhibit the phosphodiesterase 10 (PDE10) enzyme. "The award of this milestone payment reaffirms the strength of the preclinical data generated by our schizophrenia program," said Gregory A. Demopulos, M.D., Chairman and CEO of Omeros. "We believ...

Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C

... Company reaffirms its innovation leadership and long-term commitment to hepatitis research KENILWORTH, N.J., Nov. 24 /PRNewswire-FirstCall/ -- Schering-Plough ...

Parasites That Live Inside Cells Use Loophole to Thwart Immune System

...at these pathogens have evolved to exploit a biological loophole in the immune system," Murray said. "This discovery offers two important insights. It reaffirms the notion that pathogens have an incredibly diverse way of manipulating their hosts. And it reveals a new pathway by which a pathogen can induce an e...

Bronchitol Cystic Fibrosis Dose Trial Results Positive

...), +3.9% on 240 mg, +1.5% on 120 mg and -0.6% on 40 mg. Pharmaxis Chief Executive Officer Alan Robertson said, "The excellent result from this trial reaffirms that the 400 mg Bronchitol dose being used in the Phase 3 trials is optimal for its clinical effectiveness. We look forward to the results from the on...

CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina

...36 study. "This new subgroup analysis shows consistent safety and efficacy across a broader group of angina patients than those studied previously and reaffirms ranolazine as an option for treating chronic angina." Study Design MERLIN-TIMI 36 (Metabolic Efficiency with Ranolazine for Less Ischemia in Non-S...

Smokefree Workplace Law Reduces Heart Attacks 59% Among Nonsmokers, New Research Shows

...g because it is the first to examine the impact of a smokefree workplace law on the heart health of nonsmokers, rather than the general population. It reaffirms the conclusions of the landmark 2006 U.S. Surgeon General's Report, The Health Consequences of Involuntary Exposure to Secondhand Smoke Exposure, whic...

Reaffirms in Medical Products

Eppendorf Research Series 2100 Fixed-volume Pipette, 20 l

Description:...ptimally suited for use with original Eppendorf pipette tips, they provide the highest level of performance for all volume ranges. The Research Family reaffirms the established precision and reliability of Eppendorf while innovative design features make everyday use more efficient, comfortable and strain-free....
Company:Eppendorf North America

Eppendorf Research Series 2100 Fixed-volume Pipette, 5 l

Description:...ptimally suited for use with original Eppendorf pipette tips, they provide the highest level of performance for all volume ranges. The Research Family reaffirms the established precision and reliability of Eppendorf while innovative design features make everyday use more efficient, comfortable and strain-free....
Company:Eppendorf North America

Eppendorf Research Series 2100 Fixed-volume Pipette, 10 l

Description:...ptimally suited for use with original Eppendorf pipette tips, they provide the highest level of performance for all volume ranges. The Research Family reaffirms the established precision and reliability of Eppendorf while innovative design features make everyday use more efficient, comfortable and strain-free....
Company:Eppendorf North America

Eppendorf Research Series 2100 Fixed-volume Pipette, 25 l

Description:...ptimally suited for use with original Eppendorf pipette tips, they provide the highest level of performance for all volume ranges. The Research Family reaffirms the established precision and reliability of Eppendorf while innovative design features make everyday use more efficient, comfortable and strain-free....
Company:Eppendorf North America

Reaffirms in Biological News

Parkinson's Disease Foundation announces award of $150,000

...tt, Executive Director of the Parkinson's Disease Foundation, said, "PDF is pleased to support the research of Dr. Emborg and Dr. Zhang. This project reaffirms PDF's commitment to funding research of the highest caliber that may help us to understand and treat Parkinson's." This grant is part of PDF's four...

CSC Identity Labs Headquarters Relocates to West Virginia

...est Virginia University and the National Science Foundation Center for Identification Technology Research. "CSC's expanded presence in West Virginia reaffirms our commitment to the Department of Defense as we support its identity management efforts to ensure citizens and soldiers are safer today more than ev...

Large-scale genomics project will hunt genes behind common childhood diseases

...and most comprehensive pediatric networks, we have a sizable base of patients and families from which to collect data. This focused effort in genomics reaffirms that we are absolutely committed to finding cures for childhood diseases." The Human Genome Project compiled the sequence of DNA bases in all 23 c...

Female sex hormones play a vital role in defense against sexually transmitted diseases

...u Kaushic, assistant professor and supervisor of the studies, says the implication of this work is quite significant. "The research clearly shows, and reaffirms previous research, that in female mice, sex hormones have a profound effect on susceptibility to sexually transmitted infections as well as on the bod...

Reaffirms in Biological Technology

Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010

First-Quarter 2009 Highlights: - GAAP diluted EPS increased 16.0 percent to $0.58 from $0.50 in first-quarter 2008 - Diluted EPS, excluding $0.05 in amortization of intangible assets from the 2003 spin-off, increased 14.5 percent to $0.63 from $0.55 in first-quarter 2008 - Total net...

Genomma Lab Reaffirms Zero Ownership Stake in the Laser Hair Removal Chains Neoskin and Depilite

MEXICO CITY, Nov. 11 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma" or "the Company"), a leading Mexican over-the-counter ("OTC") pharmaceuticals and personal care products company announced today that it owns no shares in the laser hair removal chain "Neoskin,...

Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares.

ST. LOUIS, Oct. 21 /PRNewswire-FirstCall/ -- HIGHLIGHTS: 2008 Results (all percentage comparisons are to comparable periods in 2007): -- Q3 2008 Sales Driven By Consistent Research Sales Gain: Q3 2008 sales increased 7.4% to $540.6 million. Currency added 3.1% to organic growth ...

China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance

HARBIN, China, Oct. 14 /Xinhua-PRNewswire-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (NASDAQ: CSKI ), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), announced today that it...

Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals

Company Reiterates $3.00 per Share Proposal is Best and Final Offer INDIANAPOLIS, Aug. 4 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) today reaffirmed that its $3.00 per share purchase offer for SGX Pharmaceutical, Inc. (Nasdaq: SGXP ) represents its best and final offer fo...

IPC The Hospitalist Company, Inc. Reaffirms Guidance for 2008

NORTH HOLLYWOOD, Calif., June 17 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM ), a leading national hospitalist physician group practice, today reaffirmed its guidance for full year 2008 revenue to be in the range of $239 million to $245 million and full year 2008...

Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance

BASINGSTOKE, England and PHILADELPHIA, April 25 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three months to March 31, 2008. Q1 2008 Financial Highlights - Product sales up 37% to $632m - New produ...

Study Reaffirms Superiority of Trofile(TM) Assay

Pfizer Study Finds Pathway's SensiTrop(TM) Assay Is Discordant in Detecting HIV Tropism with Clinically Validated Trofile SOUTH SAN FRANCISCO, Calif., Dec. 19 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM ) today announced that Pfizer Inc (NYSE: PFE), the manufa...

ACT Announces Partnership With Gilead Sciences Inc.

...nd financial success. Walter H Singer, Founder and CEO of ACT, was quoted as saying, "The addition of Gilead Sciences Inc. is extremely gratifying and reaffirms the underlying reasons for ACT's success. Coupled with personal level service, ACT's recycling programs have allowed 94% of our clients' waste product...

PDL BioPharma Announces First Quarter 2009 Financial Results

...butable to sales of Raptiva were $3.9 million or 1.3% of total revenue from continuing operations. 2009 Financial Guidance PDL reaffirms its previous revenue guidance and continues to anticipate strong revenue growth in 2009 increasing from 2008 to a range of $310 to $325 million despit...